Weight loss surgery has dominated obesity treatment for over two decades. Surgeons could not keep up with demand. Hospital waiting lists stretched months long. Then, almost overnight, the operating rooms started getting quieter. The reason is sitting in millions of medicine cabinets. GLP-1 drugs – Ozempic, Wegovy, Mounjaro, Zepbound – have surged so dramatically that […]
For millions of people managing type 2 diabetes or considering GLP-1 therapy for weight loss, injections have always been the biggest barrier. That barrier may now be coming down. Novo Nordisk has launched an oral version of its GLP-1 medication – a pill that delivers the same active mechanism as injectable semaglutide, without a needle […]
If you are taking Mounjaro for weight loss, new research has uncovered something you need to know: tirzepatide – the active ingredient in Mounjaro – appears to cause significantly more lean muscle mass loss compared to semaglutide (Ozempic, Wegovy). This matters because losing muscle is not just a cosmetic concern. Muscle is your metabolic engine. […]
A new weight loss drug called survodutide just made headlines after a major Phase 3 clinical trial showed it delivers 16.6% average body weight reduction – roughly 39 pounds – outperforming both Ozempic and Zepbound in early comparisons. If you have been following the GLP-1 revolution in weight loss medicine, this is the biggest development […]